Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management dilemmas in prostate cancer

R Bruskewitz1, P P Carbone

  • 1Division of Urology, Department of Medicine, University of Wisconsin Medical School, Madison, USA.

Hospital Practice (1995)
|January 15, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cryptococcus neoformans pericarditis associated with Hodgkin's disease.

Annals of internal medicine·2013
Same author

Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282.

Annals of oncology : official journal of the European Society for Medical Oncology·2001
Same author

Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplants.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2001
Same author

Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia.

Urology·2001
Same author

A comparison of two phase III multicenter, placebo-controlled studies of tamsulosin in BPH.

Advances in therapy·2001
Same author

Bioavailability study of oral liquid and tablet forms of alpha-difluoromethylornithine.

Clinical cancer research : an official journal of the American Association for Cancer Research·2000

Many men have undetected prostate tumors that rarely become significant. Clinical trials are needed to prove prostate-specific antigen (PSA) screening and treatments benefit patients needing guidance on screening and treatment decisions.

Area of Science:

  • Oncology
  • Urology
  • Medical Diagnostics

Background:

  • Prostate cancer is common, with many undetected tumors.
  • Only a small fraction of prostate tumors become clinically significant.

Observation:

  • Prostate-specific antigen (PSA) screening is widely used.
  • Treatment strategies for prostate cancer vary.

Findings:

  • Demonstrating the benefits of PSA screening and treatment strategies requires significant time.
  • Patients face complex decisions regarding screening and treatment options.

Implications:

  • There is a need for better tools and evidence to guide patient decisions.
  • Further research is required to establish definitive screening and treatment protocols.

Related Experiment Videos